SAMANTHA MACPHAIL: Open Payments
NPI 1831734565 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,243 in 128 payments from 20 companies in 2025. Trend: 2023 $946 · 2024 $2,144 · 2025 $2,243
Food & beverage: $2,243
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 19 | $390 |
| ABBVIE INC. | 25 | $315 |
| Novartis Pharmaceuticals Corporation | 13 | $235 |
| Journey Medical Corporation | 7 | $202 |
| Amgen Inc. | 7 | $192 |
| Incyte Corporation | 13 | $166 |
| Lilly USA, LLC | 11 | $149 |
| Organon LLC | 5 | $130 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $119 |
| Regeneron Healthcare Solutions, Inc. | 4 | $69 |
Products named: NEMLUVIO, SKYRIZI, Rhapsido, OTEZLA, OPZELURA, TALTZ, VTAMA, DUPIXENT.
Industry payments across NY — which companies pay providers there.
